News

Keep up with the latest news from the NCI Center for Biomedical Informatics and Information Technology (CBIIT) and the data science communities.

Think AI is still out of reach for most clinicians? A new NCI study examines the feasibility of bringing AI to the clinic, using a publicly available platform and an AI-assisted model for detecting prostate cancer on MRI scans.

What’s the best role for AI in screening for breast cancer? This study, partially funded by NCI, helps define that role by looking at how well AI performed in finding hard-to-detect cancers.

Want to use your data science skills to find better cancer treatments? See how these NCI-funded researchers working with artificial intelligence (AI) used information from a survival model to refine treatment for glioblastoma.

Learn about this NCI-supported, comprehensive visual and interactive system for analyzing cell-to-cell interactions in 3D image data.

Having trouble discerning what makes a successful AI model? NCI is leading the way in developing concrete guidelines for building, evaluating, and reporting on AI-assisted prostate imaging models.

See how a new AI-driven tool can help you measure micronuclei and similar structures to study their underlying biology, enabling you to more efficiently measure and characterize these tiny structures.

Read about a new collaboration between NCI and a company that develops AI-powered solutions for cancer diagnostics and therapeutics. NCI will be applying these tools to help advance research into personalized treatment for patients with cancer.

Use the Medical Image De-Identification Benchmark (MIDI-B) to assess the effectiveness of your DICOM image de-identification tool or algorithm. MIDI-B provides a platform for you to measure the automated removal of protected health and personally identifiable information from medical images.

NCI-funded researchers are applying AI to digital pathology images to better understand cellular features, such as “nuclear wrinkling.” Such extreme wrinkling and folding is a hallmark of cancer.

NCI researchers debuted a new deep learning model that could help you decipher the cancer tumor’s microenvironment. The model holds a lot of promise for predicting which patients are most likely to benefit from checkpoint inhibitors.